MedPath

Evaluation of Correlations Between Radiologic Features and Pathologic Subtypes of GGO LUAD Via WMS (ECTOP-1011)

Completed
Conditions
Adenocarcinoma of Lung
Registration Number
NCT05252676
Lead Sponsor
Fudan University
Brief Summary

This study is one of the Eastern Cooperative Thoracic Oncology Projects (ECTOP-1011). It aims to evaluate the correlations between radiologic features and pathologic subtypes of ground glass opacity featured lung adenocarcinoma via whole-mount section.

Detailed Description

The pathological lepidic growth pattern was believed to relate to the ground-glass component, whereas invasive adenocarcinoma patterns relate to the solid component. However, the solid components might be fibrosis rather tumor; and previous studies demonstrated the ground-glass components might be invasive lesions. Therefore, it is of considerable significance to establish the correlations between radiologic features and pathologic subtypes of ground glass opacity featured lung adenocarcinoma.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
103
Inclusion Criteria
  • Ground glass opacity featured lung nodule diagnosed by thin-section computed tomography(TSCT)
  • Pre-operation clinical IA stage
  • Pulmonary lobectomy or segmentectomy
  • Provision of informed consent
Read More
Exclusion Criteria
  • Postoperative diagnosis of non-adenocarcinoma or mucinous adenocarcinoma
  • The surgical specimens fail to satisfy requirement of inflation and formalin fixation
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of correlations between radiologic features and pathologic subtypesabout 14 days

Evaluation of correlations between radiologic features and pathologic subtypes of ground glass opacity featured lung adenocarcinoma

Secondary Outcome Measures
NameTimeMethod
Specificity, Sensitivity, and Repeatabilityabout 14 days

The specificity, sensitivity, and repeatability of invasiveness diagnosis based on the Whole-Mount Section

Trial Locations

Locations (1)

Fudan University Cancer Center

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath